Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999

被引：311
作者：
Hoban, DJ
Doern, GV
Fluit, AC
Roussel-Delvallez, M
Jones, RN
机构：
[1] Hlth Sci Ctr, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada
[2] Univ Iowa, Coll Med, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
[3] Univ Utrecht Hosp, Eijkman Winkler Inst Clin Microbiol, Utrecht, Netherlands
[4] Chru Lille Hop Calmette, Bacteriol Lab, Lille, France
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 32卷
关键词：
D O I：
10.1086/320181
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The in vitro activities of numerous antimicrobials against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis from patients with bloodstream and respiratory tract infections in the United States, Canada, Europe, Latin America, and the Asia-Pacific region were studied in the SENTRY Antimicrobial Surveillance Program. Penicillin resistance (minimum inhibitory concentration, greater than or equal to2 mug/mL) was noted in all 5 geographic regions, and a high and increasing rate of macrolide resistance among S. pneumoniae isolates was observed. Elevated rates of resistance to clindamycin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline were seen. beta -Lactamase-mediated resistance in H. influenzae to amoxicillin and variable trimethoprim-sulfamethoxazole resistance by region were documented. Resistance to several drugs continues to emerge among pneumococci worldwide, but more stable resistance patterns have been noted for H. influenzae and M. catarrhalis. Continued surveillance of this pathogen group appears to be prudent.
引用
收藏
页码：S81 / S93
页数：13
相关论文
共 44 条
[1]  
[Anonymous], M100S10 NCCLS
[2]   Fluoroquinolone-resistant Haemophilus influenzae:: Frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America) [J].
Biedenbach, DJ ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (04) :255-259
[3]   Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children [J].
Castaneda, E ;
Leal, AL ;
Castillo, O ;
DeLaHoz, F ;
Vela, MC ;
Arango, M ;
Trujillo, H ;
Levy, A ;
Gama, ME ;
Calle, M ;
Valencia, ML ;
Parra, W ;
Agudelo, N ;
Mejia, GI ;
Jaramillo, S ;
Montoya, F ;
Porras, H ;
Sanchez, A ;
Saa, D ;
DiFAbio, JL ;
Homma, A ;
Rios, AM ;
Ovalle, MV ;
Serrato, J ;
Navarrete, MR ;
Garcia, M ;
Aristizabal, G ;
Tovar, A ;
Paredes, C ;
Arenas, A ;
Zapata, C ;
Robledo, J ;
Correa, N ;
Suarez, C ;
Garcia, V ;
Gallardo, LM ;
Moreno, A ;
Villamarin, N ;
Bohorquez, AL ;
Lopez, P ;
Guerrero, J .
MICROBIAL DRUG RESISTANCE, 1997, 3 (02) :147-152
[4]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[5]   Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America [J].
Diekema, DJ ;
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Kugler, KC ;
Beach, ML ;
Sader, HS .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) :257-271
[6]   Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia:: Report from the SENTRY Antimicrobial Surveillance Program (1998) [J].
DiPersio, JR ;
Jones, RN ;
Barrett, T ;
Doern, GV ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (02) :131-135
[7]   Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study [J].
Doern, GV ;
Brueggemann, AB ;
Pierce, G ;
Holley, HP ;
Rauch, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :292-297
[8]   Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study [J].
Doern, GV ;
Brueggemann, AB ;
Pierce, G ;
Hogan, T ;
Holley, HP ;
Rauch, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2884-2886
[9]   The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada -: 1997 results from the SENTRY Antimicrobial Surveillance Program [J].
Doern, GV ;
Pfaller, MA ;
Erwin, ME ;
Brueggemann, AB ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) :313-316
[10]   Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98 [J].
Doern, GV ;
Brueggemann, AB ;
Huynh, H ;
Wingert, E ;
Rhomberg, P .
EMERGING INFECTIOUS DISEASES, 1999, 5 (06) :757-765
12345